UNH241227P435000
- 0.01
- -0.04-80.00%
UnitedHealth Newsroom
UnitedHealth, Amedisys Waive Right to Terminate Merger Pact
US Equities Markets End Lower Friday as Big Tech Slumps
Can You Bet On Luigi Mangione's Fate? Betting Platforms, Regulators Wrestle With Limits In Growing Market
Equities Fall Intraday as Mega-Cap Stocks Weigh
Nasdaq Leads Market Losses in Midday Trading
US Equity Indexes Lower in Midday Trading
Top Midday Stories: UnitedHealth, Amedisys Extend Deal-Close Deadline; OpenAI Mulling a For-Profit Structure
The US stock market is expected to reach new highs in 2025. How to seize the opportunity? The three most loved Index component stocks on Wall Street have been revealed!
Bank of America stated that technology giants are likely to continue outperforming the Large Cap by 2025. The bank's derivatives Analyst, Benjamin Bowler, explained that interest rate cuts and the ongoing AI boom could lead to further gains for large technology companies in the United States.
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
UnitedHealth (UNH.US) and Amedisys (AMED.US) have extended the merger agreement deadline to next year.
UnitedHealth (UNH.US) and Amedisys (AMED.US) submitted documents on Friday indicating that the two companies have agreed to extend the deadline for completing the $3.3 billion merger agreement until next year, primarily because the Trade is under review by the USA Department of Justice. Previously, the Department of Justice and three states filed a lawsuit to block the Trade due to concerns that it would reduce competition in the home Veterinary Services market. The documents state that the two companies have reached a new waiver agreement, extending the merger deadline to 10 days after the court issues a final ruling in the lawsuit or until December 31, 2025.
Sector Update: Health Care
UnitedHealth Group, Amedisys Extend Deadline for $3.3 Billion Merger Deal
UnitedHealth, Amedisys Waive Right to Terminate Merger
Express News | Amedisys Shares up 2.4% Premarket After Co and UnitedHealth Extend Deadline to Close Merger Agreement
Express News | Amedisys: UnitedHealth Group Entered Into Waiver, Includes That Regulatory Break Fee Under Deal to Be $275 Mln, May Escalate for Failing to Meet Some Timing Milestones up to $325 Mln
Medical stocks welcome a rebound opportunity: three major star companies may become investment highlights in 2025.
In 2024, the performance of the Medical Industry is disappointing for investors, but 2025 may bring a glimmer of hope.
3 Healthcare Stocks to Buy for a 2025 Rebound
Health Care Up on Defensive Bias -- Health Care Roundup
How Medicare Plans, Working With PBMs, Fueled -2-
UnitedHealth Group Stock Added to Raymond James Current Favorite List